TRCT
PFE icon

Tower Research Capital (TRC)’s Pfizer PFE Stock Holding History

Tower Research Capital (TRC)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
37,406
-164,577
-81% -$4.38M 0.03% 520
2025
Q4 		$5.03M Buy
201,983
+134,026
+197% +$3.38M 0.12% 144
2025
Q3 		$1.73M Sell
67,957
-89,644
-57% -$2.21M 0.05% 328
2025
Q2 		$3.82M Buy
157,601
+81,494
+107% +$1.9M 0.1% 182
2025
Q1 		$1.93M Sell
76,107
-245,601
-76% -$6.43M 0.06% 292
2024
Q4 		$8.53M Buy
321,708
+75,034
+30% +$2.04M 0.17% 86
2024
Q3 		$7.14M Buy
246,674
+66,718
+37% +$1.95M 0.19% 69
2024
Q2 		$5.04M Buy
179,956
+78,576
+78% +$2.16M 0.09% 193
2024
Q1 		$2.81M Sell
101,380
-604,099
-86% -$16.8M 0.07% 207
2023
Q4 		$20.3M Buy
705,479
+521,677
+284% +$15.8M 0.25% 67
2023
Q3 		$6.1M Buy
183,802
+90,896
+98% +$3.21M 0.19% 86
2023
Q2 		$3.41M Buy
92,906
+121
+0.1% +$4.71K 0.11% 115
2023
Q1 		$3.79M Sell
92,785
-557
-0.6% -$24.1K 0.12% 110
2022
Q4 		$4.78M Sell
93,342
-383,129
-80% -$18.4M 0.2% 64
2022
Q3 		$20.9M Buy
476,471
+203,813
+75% +$9.9M 0.34% 46
2022
Q2 		$14.3M Sell
272,658
-484,586
-64% -$24.7M 0.32% 48
2022
Q1 		$39.2M Buy
757,244
+421,347
+125% +$21.9M 0.37% 46
2021
Q4 		$19.8M Buy
335,897
+208,335
+163% +$10.3M 0.34% 46
2021
Q3 		$5.49M Sell
127,562
-173,877
-58% -$7.7M 0.14% 90
2021
Q2 		$11.8M Sell
301,439
-234,731
-44% -$9.13M 0.31% 46
2021
Q1 		$19.4M Buy
536,170
+381,362
+246% +$13.5M 0.33% 55
2020
Q4 		$5.7M Buy
154,808
+56,052
+57% +$2.06M 0.17% 57
2020
Q3 		$3.44M Buy
98,756
+7,272
+8% +$255K 0.04% 158
2020
Q2 		$2.84M Buy
+91,484
New +$3.11M 0.12% 139
2019
Q4 		– Sell
-161,665
Closed -$5.51M – 4171
2019
Q3 		$5.51M Buy
161,665
+106,429
+193% +$3.87M 0.38% 31
2019
Q2 		$2.27M Sell
55,236
-50,199
-48% -$1.99M 0.15% 93
2019
Q1 		$4.25M Sell
105,435
-15,838
-13% -$634K 0.26% 48
2018
Q4 		$5.02M Buy
121,273
+74,601
+160% +$3.1M 0.36% 51
2018
Q3 		$1.95M Sell
46,672
-171,650
-79% -$6.61M 0.14% 108
2018
Q2 		$7.51M Buy
218,322
+217,479
+25,798% +$7.43M 0.42% 39
2018
Q1 		$28K Sell
843
-47,584
-98% -$1.64M ﹤0.01% 2000
2017
Q4 		$1.67M Buy
48,427
+48,216
+22,851% +$1.64M 0.21% 96
2017
Q3 		$7K Sell
211
-6,900
-97% -$222K ﹤0.01% 3213
2017
Q2 		$227K Buy
+7,111
New +$224K 0.03% 311
2017
Q1 		– Sell
-139,613
Closed -$4.3M – 3698
2016
Q4 		$4.3M Buy
139,613
+134,595
+2,682% +$4.11M 0.47% 36
2016
Q3 		$161K Sell
5,018
-99,211
-95% -$3.32M 0.02% 589
2016
Q2 		$3.48M Buy
104,229
+86,216
+479% +$2.75M 0.33% 54
2016
Q1 		$507K Buy
18,013
+17,802
+8,437% +$508K 0.08% 175
2015
Q4 		$6K Sell
211
-526
-71% -$16.5K ﹤0.01% 2801
2015
Q3 		$22K Sell
737
-2,468
-77% -$79.1K ﹤0.01% 1649
2015
Q2 		$102K Sell
3,205
-19,572
-86% -$638K 0.01% 797
2015
Q1 		$752K Buy
22,777
+19,274
+550% +$613K 0.09% 134
2014
Q4 		$104K Sell
3,503
-58,975
-94% -$1.69M 0.01% 594
2014
Q3 		$1.75M Buy
62,478
+61,465
+6,068% +$1.73M 0.2% 99
2014
Q2 		$29K Sell
1,013
-15,755
-94% -$449K ﹤0.01% 1618
2014
Q1 		$511K Buy
+16,768
New +$500K 0.07% 205
2013
Q4 		– Sell
-125,316
Closed -$3.42M – 4823
2013
Q3 		$3.42M Buy
125,316
+117,098
+1,425% +$3.19M 0.37% 53
2013
Q2 		$218K Buy
+8,218
New +$227K 0.02% 245

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tower Research Capital (TRC)'s PFE Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Pfizer (PFE) stake by 81% in Q1 2026, selling an estimated $4.38M and leaving 37,406 shares worth $1.05M. The position accounts for 0.03% of the portfolio, ranked #520.

Tower Research Capital (TRC) first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $39.2M in Q1 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Tower Research Capital (TRC) held 37,406 shares of Pfizer worth $1.05M as of Q1 2026.
  • Tower Research Capital (TRC) sold 164,577 Pfizer shares in Q1 2026, an estimated $4.38M.
  • Pfizer made up 0.03% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #520 holding.
  • Tower Research Capital (TRC) first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Pfizer position peaked at $39.2M in Q1 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.